The 12th Annual World Health Care Congress convenes decision makers from all sectors of health care to catalyze change. In 2015, faculty focus on critical challenges and opportunities including the impact of ACA implementation on health care businesses one year in, payer and provider consolidation, new approaches to value-based payment, and novel partnerships with the true potential to move the needle on care coordination and delivery.
The BIO Asia International Conference, co-hosted by the Biotechnology Industry Organization (BIO), BioCentury and the Japan Bioindustry Association (JBA), brings together the global biotechnology and pharmaceutical industry to explore licensing and research collaborations in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market.
This event will offer a unique chance to benchmark with regional as well as global clinical and medical affairs experts to discuss best practices that apply in this region and an ideal opportunity to build contacts and networks for the future.
3 EVENTS IN ONE:
Achieving Clinical & Regulatory Excellence in the TMENA & GCC Region
Optimizing Clinical Operations & Patient Recruitment in TMENA
This forum will bring together experts from all stakeholder groups (i.e. researchers, regulators, patient groups, health technology assessors) for an important and timely debate and to share knowledge on how to develop more effective, safe, affordable and patient-relevant oncology therapies to the patient.
4 EVENTS IN ONE:
Strategic approaches to enhance cancer clinical development
Intelligent early-phase & translational oncology clinical development
Maximising clinical performance through enhanced oncology trial design
Best practices in oncology patient recruitment & site engagement
The event will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible.
4 EVENTS IN ONE:
Developing and Demonstrating „Value“ for Specialty Pharma Market Access
Achieving Market Access for High-Value Oncology & Specialty Therapeutics
Thank you for your interest in Pharma and Healthcare Insight
You will shortly receive an e-mail with link(s) to a full version of the newsletter(s) you selected. A member of our Client Services team will be in touch soon to receive your feedback on the newsletters and arrange a convenient time for a free demonstration of the full service. If your enquiry is urgent, please email our team here Thanks, BMI Research